From: Budgetary impact of increasing use of peritoneal dialysis over haemodialysis in Spain
Frequency/ % of use | Cost15 | |
---|---|---|
PD sessions | ||
CAPD, weekly frequency | 7.0 | €52.35/day |
APD, weekly frequency | 7.0 | €72.27/day* |
Low-volume APD, % patients | 60.0% | €65.88/day |
High-volume APD, % patients | 40.0% | €81.87/day |
HD sessions | ||
HD received at home, weekly frequency | 5.0 | €140.90/day |
HD received at hospital, weekly frequency | 3.0 | €252.27/day |
HD received at CHDC, weekly frequency | 3.0 | €123.91/day |
HDF sessions | ||
HDF received at home, weekly frequency | 5.0 | €162.04/day |
HDF received at hospital, weekly frequency | 3.0 | €290.11/day |
HDF received at CHDC, weekly frequency | 3.0 | €142.49/day |
CAPD and APD supplements | ||
Icodextrin [6], % patients | 60% | €7.1 |
Sodium bicarbonate [6], % patients | 40% | €14.0 |
Training | ||
PD [6], sessions per patient | 7.0 | €146.3 |
HD [17], sessions per patient | 24.0 | €252.3 |
Pharmacological costs derived from the use of erythropoietic agents | ||
PD [6], % patients | 39.0 | €1 327.6**[16] |
HD [6], % patients | 57.0 | €2 540.3**[16] |